BioVendor R&D participates significantly in the activities of BIOCEV and CEITEC technology clusters, which serve as a platform for promoting the common goals of companies and universities.
We are currently cooperating on two grant projects:
The project conducted within the TACR’s call of Zéta is focused on the development and validation of innovative detection systems for the determination of urinary miRNA in the diagnosis of urological tumours.
The second joint project is of the RNADIAGON international consortium, whose development and research in the field of the use of non-coding RNA within oncological diagnostics was supported by a grant from Horizon 2020 RISE. In addition to the research team of prof. Slabý from CEITEC and Biovendor R&D, teams from the universities in Graz, Hamburg and Ferrera, as well as the team of Professor Calin from the Anderson Cancer Center in Texas are involved in the project.